Labetuzumab govitecan, CAS [[1469876-18-3]]

Produktübersicht

• Artikelname: Labetuzumab govitecan, CAS [[1469876-18-3]]
• Artikelnummer: MCE-HY-P99681
• Hersteller Artikelnummer: HY-P99681
• Alternativnummer: MCE-HY-P99681-1MG,MCE-HY-P99681-5MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: IMMU 130, hMN-14-SN-38

Produktbeschreibung

Labetuzumab govitecan (IMMU 130) is an Anti-CEACAM5/SN-38 antibody-drug conjugate (ADC). Labetuzumab govitecan consists of the antibody Labetuzumab, SN-38, and a pH-sensitive Linker. Labetuzumab govitecan can be used for research of cancers, such as colorectal cancer[1][2][3].

Produkteigenschaften

• Molekulargewicht: 154000 (average)
• Reinheit: 98.66
• CAS Nummer: [1469876-18-3]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs)

Anwendungsbeschreibung

• Anwendungsbeschreibung: ADC Related